STAASTAAR Surgical Company

$860M

Q2 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$62M+77.2% YoY

Gross Profit

$49M78.9% margin

Operating Income

$11M17.1% margin

Net Income

$9M13.7% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

+22.9%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$3M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$294M

Total Liabilities

$60M

Stockholders' Equity

$235M

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$35M	+77.2%
Gross Profit	$49M	$24M	+101.4%
Operating Income	$11M	-$1M	+1109.4%
Net Income	$9M	-$1M	+831.0%

Revenue Segments

Implantable Collamer Lenses

$59M95%

Intraocular Lenses

$3M5%

Other Surgical Products

$58,0000%

STAA Q2 2021 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena